✦ LIBER ✦

Outcome of selected breast cancer patients with micrometastasis or isolated tumor cells in sentinel node biopsy and no completion axillary lymph node dissection

✍ Scribed by Tuomo J. Meretoja; Jaana H. Vironen; Päivi S. Heikkilä; Marjut H. Leidenius

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 75 KB
Volume: 102
Category: Article
ISSN: 0022-4790
DOI: 10.1002/jso.21608

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term morbidity of patients with ear

Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection

✍ Tobias Schulze; Jörg Mucke; Jorn Markwardt; Peter M. Schlag; Andreas Bembenek 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

Optimal use of sentinel lymph node biops

Optimal use of sentinel lymph node biopsy versus axillary lymph node dissection in patients with breast carcinoma : A decision analysis

✍ Sandra L. Wong; Troy D. Abell; Celia Chao; Michael J. Edwards; Kelly M. McMaster 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

## Background: There are no data available from randomized controlled trials that compare the efficacy of sentinel lymph node (sln) biopsy with level i/ii axillary lymph node dissection (alnd) in patients with breast carcinoma. we performed a formal decision analysis to determine whether sln biopsy

Low locoregional failure rates in select

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection

✍ Rosa F. Hwang; Ana M. Gonzalez-Angulo; Min Yi; Thomas A. Buchholz; Funda Meric-B 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract ## BACKGROUND. The role for completion axillary dissection (CLND) in patients with breast cancer who have tumor‐positive sentinel lymph nodes (SLN) has been questioned. The objective of this study was to examine the long‐term safety of avoiding CLND in selected patients with positive S

The prevalence of and risk factors for f

The prevalence of and risk factors for four or more metastatic axillary lymph nodes in breast cancer patients undergoing sentinel node biopsy

✍ M. Leidenius; L. Vaalavirta; P. Heikkilä; K. von Smitten; K. Salmenkivi 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 1 views

The consequences of long-time arm morbid

The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance

✍ M. Leidenius; M. Leivonen; J. Vironen; K. von Smitten 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 84 KB

Feasibility and Accuracy of Sentinel Lym

Feasibility and Accuracy of Sentinel Lymph Node Biopsy After Preoperative Chemotherapy in Breast Cancer Patients With Documented Axillary Metastases

✍ Jeannie Shen; Michael Z. Gilcrease; Gildy V. Babiera; Merrick I. Ross; Funda Mer 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB

## Abstract ## BACKGROUND. The feasibility and accuracy of sentinel lymph node (SLN) biopsy in patients with breast cancer after preoperative chemotherapy has been demonstrated in a number of large, single‐institution studies. However, a relative contraindication to SLN biopsy after preoperative c